Evidence of reduced treatment adherence among HIV infected paediatric and adolescent populations in Nairobi at the onset of the UNAIDS Universal Test and Treat Program
- PMID: 29452597
- PMCID: PMC5816400
- DOI: 10.1186/s13104-018-3205-0
Evidence of reduced treatment adherence among HIV infected paediatric and adolescent populations in Nairobi at the onset of the UNAIDS Universal Test and Treat Program
Abstract
Objective: We conducted a retrospective cohort study to evaluate the efficacy of the World Health Organization (WHO) "Universal Test and Treat" (UTT) policy, initiated in Kenya in September 2016. Under this policy, every human immunodeficiency virus (HIV)-infected person should be initiated on antiretroviral therapy (ART). We compared intra- and inter-group viral suppression and ART adherence rates for pre-UTT (initiated on ART in March-August 2016) and UTT groups (initiated in September 2016). The study was conducted in a community outreach Program in Nairobi with 3500 HIV-infected children enrolled.
Results: 122 children and adolescents were initiated on first-line ART pre-UTT, and 197 during the UTT period. The 6 month viral suppression rate was 79.7% pre-UTT versus 76.6% UTT (P < 0.05). Suboptimal adherence was higher in the UTT than pre-UTT period (88 of 197, 44.7% and 44 of 122, 34%; P < 0.001). The decrease in adherence was greater among orphans (91.7% pre-UTT and 87.2% UTT, P = 0.001) and children 11-18 years. Our results show that successful implementation of the UTT policy in Africa is challenged by an increased risk of suboptimal adherence. There is a need to develop extra strategies to support adherence, especially among orphans and teenagers.
Keywords: 90-90-90; Adherence; Antiretroviral therapy; Children; HIV; Kenya; Universal test and treat; Virologic failure.
Figures
Similar articles
-
Retention on antiretroviral therapy during Universal Test and Treat implementation in Zomba district, Malawi: a retrospective cohort study.J Int AIDS Soc. 2019 Feb;22(2):e25239. doi: 10.1002/jia2.25239. J Int AIDS Soc. 2019. PMID: 30734510 Free PMC article.
-
Twelve months antiretroviral therapy retention among clients newly enrolled to care and treatment services in Geita Regin, Tanzania: does universal test and treat matter?Pan Afr Med J. 2023 Sep 14;46:20. doi: 10.11604/pamj.2023.46.20.40772. eCollection 2023. Pan Afr Med J. 2023. PMID: 38035160 Free PMC article.
-
Attrition in HIV care following HIV diagnosis: a comparison of the pre-UTT and UTT eras in South Africa.J Int AIDS Soc. 2021 Feb;24(2):e25652. doi: 10.1002/jia2.25652. J Int AIDS Soc. 2021. PMID: 33605061 Free PMC article.
-
Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.Verh K Acad Geneeskd Belg. 2001;63(5):447-73. Verh K Acad Geneeskd Belg. 2001. PMID: 11813503 Review.
-
Potential challenges to sustained viral load suppression in the HIV treatment programme in South Africa: a narrative overview.AIDS Res Ther. 2021 Jan 6;18(1):1. doi: 10.1186/s12981-020-00324-w. AIDS Res Ther. 2021. PMID: 33407664 Free PMC article. Review.
Cited by
-
Evidence-based modeling of combination control on Kenyan youth HIV/AIDS dynamics.PLoS One. 2020 Nov 17;15(11):e0242491. doi: 10.1371/journal.pone.0242491. eCollection 2020. PLoS One. 2020. PMID: 33201934 Free PMC article.
-
HIV interventions across the care continuum for adolescents in high-burden countries: a systematic review and meta-analysis.EClinicalMedicine. 2024 Nov 28;78:102989. doi: 10.1016/j.eclinm.2024.102989. eCollection 2024 Dec. EClinicalMedicine. 2024. PMID: 39764546 Free PMC article.
-
Brief Report: Time to Repeat Viral Load Testing Among Unsuppressed Adolescents and Young Adults Living With HIV in Kenya.J Acquir Immune Defic Syndr. 2020 Dec 15;85(5):606-611. doi: 10.1097/QAI.0000000000002498. J Acquir Immune Defic Syndr. 2020. PMID: 32897936 Free PMC article.
-
Characterizing the HIV care continuum among children and adolescents with HIV in eastern and southern Africa in the era of "Universal Test and Treat": A systematic review and meta-analysis.J Int AIDS Soc. 2025 Jun;28(6):e26526. doi: 10.1002/jia2.26526. J Int AIDS Soc. 2025. PMID: 40515449 Free PMC article. Review.
-
Patient-mix, programmatic characteristics, retention and predictors of attrition among patients starting antiretroviral therapy (ART) before and after the implementation of HIV "Treat All" in Zimbabwe.PLoS One. 2020 Oct 19;15(10):e0240865. doi: 10.1371/journal.pone.0240865. eCollection 2020. PLoS One. 2020. PMID: 33075094 Free PMC article.
References
-
- World Health Organization (WHO). Core epidemiological HIV/AIDS estimates. 2015. http://www.who.int/hiv/data/en/. Accessed 24 Mar 2017.
-
- The Joint United Nations Programme on HIV/AIDS (UNAIDS). HIV and AIDS estimates for Kenya. 2015. http://www.unaids.org/en/regionscountries/countries/kenya. Accessed 24 Mar 2017.
-
- The Joint United Nations Programme on HIV/AIDS (UNAIDS). 90–90-90 An ambitious treatment target to help end the AIDS epidemic; JC2684. 2014. http://www.unaids.org/sites/default/files/media_asset/90-90-90_en_0.pdf. Accessed 24 Mar 2017.
-
- World Health Organization (WHO). Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection. 2016. http://www.who.int/hiv/data/en/. Accessed 24 Mar 2017. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical